{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg201630c.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["property"], "content": "<p>Three new anionic metal organic frameworks, [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>1</bold>), [Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>2</bold>),\nand [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>3</bold>) (FDAH<sub>2</sub> =\n2,5-furandicarboxylic acid, G = guest), were synthesized solvothermally\nvia a temperature tuning strategy. Compound <bold>1</bold>, synthesized\nat 90 \u00b0C, has a two-dimensional (2D) sheet structure, while <bold>2</bold> and <bold>3</bold>, synthesized at 120 and 160 \u00b0C,\nrespectively, have three-dimensional (3D) structures. Compound <bold>2</bold> has alternating hydrophobic and hydrophilic channels with\npore dimensions \u223c4.3 \u00d7 4.4 \u00c5<sup>2</sup> and \u223c5.6\n\u00d7 6.2 \u00c5<sup>2</sup>, respectively. Compound <bold>3</bold> has only one type of pore with dimensions of \u223c5.3 \u00d7\n6.2 \u00c5<sup>2</sup>. All three compounds have eight connected Zn<sub>3</sub>(RCOO)<sub>8</sub> nodes as building units and are anionic,\nwith dimethyl ammonium cations present inside the channels to balance\ncharge. Compounds <bold>1</bold>, <bold>2</bold>, and <bold>3</bold> are supramolecular isomers with general formula [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]<sub>\n<italic toggle=\"yes\">n</italic>\n</sub>.</p>", "clean_text": "Three new anionic metal organic frameworks, [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (1), [Zn3(FDA)4(Me2NH2)2]\u22c5xG (2), and [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (3) (FDAH2 = 2,5-furandicarboxylic acid, G = guest), were synthesized solvothermally via a temperature tuning strategy. Compound 1, synthesized at 90 \u00b0C, has a two-dimensional (2D) sheet structure, while 2 and 3, synthesized at 120 and 160 \u00b0C, respectively, have three-dimensional (3D) structures. Compound 2 has alternating hydrophobic and hydrophilic channels with pore dimensions ~4.3 \u00d7 4.4 \u00c52 and ~5.6 \u00d7 6.2 \u00c52, respectively. Compound 3 has only one type of pore with dimensions of ~5.3 \u00d7 6.2 \u00c52. All three compounds have eight connected Zn3(RCOO)8 nodes as building units and are anionic, with dimethyl ammonium cations present inside the channels to balance charge. Compounds 1, 2, and 3 are supramolecular isomers with general formula [Zn1.5(FDA)2(Me2NH2)] n .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>Three new anionic metal organic frameworks\nwere synthesized\nsolvothermally where simultaneous control over dimensionality and\nsupramolecular isomerism is achieved via a temperature tuning strategy.</p><p>Considerable efforts have been\ndevoted to the synthesis of metal organic frameworks (MOFs) or porous\ncoordination polymers (PCPs) due to their potential application in\ncatalysis, gas/solvent storage and separation, magnetism, ion exchange,\ndrug delivery, luminescence, and the synthesis of compounds with new\nnetwork topologies and novel architectures. The controlled synthesis of MOF for desired applications is still\na great challenge, as the superstructure determines the properties\nassociated with the materials. The supramolecular isomerism is receiving\ngreat attention in crystal engineering, as the isomers show the differential\nresponse to several physical properties, owing to their crystal packing,\nand thus, they are good candidates for smart functional materials.\n<sup>d</sup> But the formation energy differences between the isomers\nare very less; hence, the prediction and control over particular structure\nbecomes more difficult.\n</p>", "clean_text": "Three new anionic metal organic frameworks were synthesized solvothermally where simultaneous control over dimensionality and supramolecular isomerism is achieved via a temperature tuning strategy.\n\nConsiderable efforts have been devoted to the synthesis of metal organic frameworks (MOFs) or porous coordination polymers (PCPs) due to their potential application in catalysis, gas/solvent storage and separation, magnetism, ion exchange, drug delivery, luminescence, and the synthesis of compounds with new network topologies and novel architectures. The controlled synthesis of MOF for desired applications is still a great challenge, as the superstructure determines the properties associated with the materials. The supramolecular isomerism is receiving great attention in crystal engineering, as the isomers show the differential response to several physical properties, owing to their crystal packing, and thus, they are good candidates for smart functional materials. d But the formation energy differences between the isomers are very less; hence, the prediction and control over particular structure becomes more difficult. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>It has\nbeen shown previously that solvent, pH, counteranion, concentration, template used, and\nreaction temperature are the factors\nwhich determine the overall structure of\nthe material, and thus, the control over the solvothermally obtained\nproduct is very difficult. Understanding the role of the above factors\nin a self-assembly process is very important for the synthesis of\ntarget materials. The temperature is one of the important factors\nwhich governs the overall structure of the material. The temperature-tuning\nstrategy is gaining interest, as the material with the novel topology,\ndifferent dimensionality, and unique properties can be made with the\nsame precursor and building unit. Systematic studies on the effect\nof temperature on the dimensionality of MOFs are very rare and was first explained by Cheetam et al., where the effect of reaction temperature has\nbeen demonstrated by thermal desolvation and subsequent changes in\nthe coordination environment. The effect of temperature on the structural\ndimensionality of supramolecular isomers where no coordinated solvents\nare present will provide another new approach along the same line\nbut has not been studied systematically.</p>", "clean_text": "It has been shown previously that solvent, pH, counteranion, concentration, template used, and reaction temperature are the factors which determine the overall structure of the material, and thus, the control over the solvothermally obtained product is very difficult. Understanding the role of the above factors in a self-assembly process is very important for the synthesis of target materials. The temperature is one of the important factors which governs the overall structure of the material. The temperature-tuning strategy is gaining interest, as the material with the novel topology, different dimensionality, and unique properties can be made with the same precursor and building unit. Systematic studies on the effect of temperature on the dimensionality of MOFs are very rare and was first explained by Cheetam et al., where the effect of reaction temperature has been demonstrated by thermal desolvation and subsequent changes in the coordination environment. The effect of temperature on the structural dimensionality of supramolecular isomers where no coordinated solvents are present will provide another new approach along the same line but has not been studied systematically.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>Herein we report three\nanionic porous MOFs synthesized solvothermally\nusing Zn(II), FDA (FDAH<sub>2</sub> = 2,5-furandicarboxylic acid)\n(1:1), and DMF at different reaction temperatures. [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>1</bold>) is a 2D sheet structure, [Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>2</bold>) is a 3D framework with alternating hydrophilic\nand hydrophobic channels, and [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>3</bold>)\nis a 3D framework synthesized at 90, 120, and 160 \u00b0C, respectively.\nCompounds <bold>1</bold>, <bold>2</bold>, and <bold>3</bold> are supramolecular\nisomers with general formula [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]<sub>\n<italic toggle=\"yes\">n</italic>\n</sub>. To the best\nof our knowledge, this is a first example where simultaneous control\nover dimensionality and supramolecular isomerism is achieved via a\ntemperature tuning strategy.</p>", "clean_text": "Herein we report three anionic porous MOFs synthesized solvothermally using Zn(II), FDA (FDAH2 = 2,5-furandicarboxylic acid) (1:1), and DMF at different reaction temperatures. [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (1) is a 2D sheet structure, [Zn3(FDA)4(Me2NH2)2]\u22c5xG (2) is a 3D framework with alternating hydrophilic and hydrophobic channels, and [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (3) is a 3D framework synthesized at 90, 120, and 160 \u00b0C, respectively. Compounds 1, 2, and 3 are supramolecular isomers with general formula [Zn1.5(FDA)2(Me2NH2)] n . To the best of our knowledge, this is a first example where simultaneous control over dimensionality and supramolecular isomerism is achieved via a temperature tuning strategy.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": "error", "content": "<p>The reaction at 90 \u00b0C yielded\ncompound <bold>1</bold>, having\n2D anionic sheet structure running parallel to the <italic toggle=\"yes\">ab</italic> plane (Figure.). The asymmetric unit contains\ntwo types of Zn centers (Zn1 and Zn2 with full and half occupancy,\nrespectively), two FDA ligands, and one dimethyl ammonium (DMA) cation.\nThe Zn1 has a distorted octahedral geometry, and Zn2 has a perfect\noctahedral geometry and is sitting at the crystallographic centrosymmetric\nposition, leading to a trinuclear cluster of three zinc ions (Zn1\u2013Zn2\u2013Zn1\u2032).\nZn1 and Zn2 are bridged by two monodentate bridging carboxylates and\nshare a common vertex. Hexacoordination of Zn1 is completed by oxygens\nfrom two carboxylate groups via a bidentate coordination mode. This\ntrimeric cluster unit with eight FDA ligands forms an eight connected\nZn<sub>3</sub>(RCOO)<sub>8</sub> node (Figure S2 of the ). Each trinuclear cluster\nis connected with four such clusters by a pair of FDA ligands on each\nside and extending the 2D net in the <italic toggle=\"yes\">ab</italic> plane. These\n2D nets arrange one above the other, forming a pseudo-3D structure.\nThe two extra-framework DMA cations and disordered solvents are present\ninside the pore formed between the four trimeric units. The PLATON analysis revealed that the porous structure\nwas composed of large voids of 1035.8 \u00c5<sup>3</sup> that represent\n45.2% per unit cell volume.</p>", "clean_text": "The reaction at 90 \u00b0C yielded compound 1, having 2D anionic sheet structure running parallel to the ab plane (Figure.). The asymmetric unit contains two types of Zn centers (Zn1 and Zn2 with full and half occupancy, respectively), two FDA ligands, and one dimethyl ammonium (DMA) cation. The Zn1 has a distorted octahedral geometry, and Zn2 has a perfect octahedral geometry and is sitting at the crystallographic centrosymmetric position, leading to a trinuclear cluster of three zinc ions (Zn1-Zn2-Zn1'). Zn1 and Zn2 are bridged by two monodentate bridging carboxylates and share a common vertex. Hexacoordination of Zn1 is completed by oxygens from two carboxylate groups via a bidentate coordination mode. This trimeric cluster unit with eight FDA ligands forms an eight connected Zn3(RCOO)8 node (Figure S2 of the ). Each trinuclear cluster is connected with four such clusters by a pair of FDA ligands on each side and extending the 2D net in the ab plane. These 2D nets arrange one above the other, forming a pseudo-3D structure. The two extra-framework DMA cations and disordered solvents are present inside the pore formed between the four trimeric units. The PLATON analysis revealed that the porous structure was composed of large voids of 1035.8 \u00c53 that represent 45.2% per unit cell volume.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Temperature dependent synthesis of porous compounds <bold>1</bold>\u2013<bold>3</bold>, and the changes in coordination environment\nof trimeric Zn units. (Color code: zinc, yellow; carbon, gray; oxygen,\nred. Hydrogen atoms and disordered solvents, and extra framework cations\nare omitted for clarity.).</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0005.tif\"></graphic>\n</fig>", "clean_text": " 1  Temperature dependent synthesis of porous compounds 1-3, and the changes in coordination environment of trimeric Zn units. (Color code: zinc, yellow; carbon, gray; oxygen, red. Hydrogen atoms and disordered solvents, and extra framework cations are omitted for clarity.).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 7, "type": "text", "classification": "error", "content": "<p>The same reaction, when performed at 120 \u00b0C,\ngave compound <bold>2</bold>, having a biporus 3D structure (Figure ). The basic structure of compound <bold>2</bold> is similar\nto that of compound <bold>1</bold>, but one of the carboxylate oxygens\nof one 2D sheet of compound <bold>2</bold> is now coordinated to the\nnext 2D layer, leading to a 3D structure. Compound <bold>2</bold> contains\ntwo types of Zn trimeric units (Zn1\u2013Zn3\u2013Zn1\u2032\nand Zn2\u2013Zn4\u2013Zn2\u2032). Interestingly, with increasing\nreaction temperature for compounds <bold>1</bold> and <bold>2</bold> from 90 to 120 \u00b0C, the distorted octahedral Zn (Zn1 and 1\u2032)\nof the trimeric unit of compound <bold>1</bold> is now transformed\nto tetrahedral (Zn1 and 1\u2032) in one unit and distorted trigonal\nbipyramidal (tbp) geometry (Zn2) in another unit in compound <bold>2</bold> (Figures  and ). The Zn2 (Zn2\u2032) and Zn4 are connected by (\u03b7<sup>1</sup>,\u03bc<sub>2</sub>) bridging monodentate carboxylate oxygen.\nThe remaining coordination of Zn2 with distorted trigonal bipyramidal\ncoordination geometry is completed by the bidentate coordination mode\nof carboxylate, forming one type of trimeric unit. The Zn1 (Zn1) and\nZn3 have similar coordination environments, only \u03bc<sub>2</sub> bridging carboxylate becomes bidentate bridging, and thus, the vertex\nsharing polyhedrons are now separated. The coordination environment\nof Zn1 is completed by monodentate carboxylate forming another trimeric\nunit. These two types of trimeric units are connected by eight FDA\nligands, respectively, which connect other trimeric units, forming\na 3D structure (Figures S3 and S4 of the ). These two types of eight connected Zn<sub>3</sub>(RCOO)<sub>8</sub> nodes give rise to two types of channels along\nthe <italic toggle=\"yes\">a</italic> axis: one is hydrophobic, and the other one\nis hydrophilic. The hydrophobic channels have dimensions of \u223c4.3\n\u00d7 4.4 \u00c5<sup>2</sup> and are lined with the hydrocarbon part\nof the aromatic furan rings (Figure ). The\nchannel contains hydrogen bonded DMF molecules arranged in such a\nway that the methyl groups will direct toward the hydrophobic walls\n(). The hydrophilic channels\nhave dimensions \u223c5.6 \u00d7 6.2 \u00c5<sup>2</sup> and are\ndecorated with furan oxygen and free carboxylic oxygen from monodentate\ncoordination of furan carboxylates (Figure ). These channels also contain hydrogen bonded DMF molecules but\nare arranged in such a way that the carbonyl oxygens will direct toward\nthe hydrophilic walls (). The\nPLATON analysis revealed that the 3D\nporous structure was composed of large voids of 2191.9 \u00c5<sup>3</sup> that represent 45.8% per unit cell volume.</p>", "clean_text": "The same reaction, when performed at 120 \u00b0C, gave compound 2, having a biporus 3D structure (Figure ). The basic structure of compound 2 is similar to that of compound 1, but one of the carboxylate oxygens of one 2D sheet of compound 2 is now coordinated to the next 2D layer, leading to a 3D structure. Compound 2 contains two types of Zn trimeric units (Zn1-Zn3-Zn1' and Zn2-Zn4-Zn2'). Interestingly, with increasing reaction temperature for compounds 1 and 2 from 90 to 120 \u00b0C, the distorted octahedral Zn (Zn1 and 1') of the trimeric unit of compound 1 is now transformed to tetrahedral (Zn1 and 1') in one unit and distorted trigonal bipyramidal (tbp) geometry (Zn2) in another unit in compound 2 (Figures  and ). The Zn2 (Zn2') and Zn4 are connected by (\u03b71,\u03bc2) bridging monodentate carboxylate oxygen. The remaining coordination of Zn2 with distorted trigonal bipyramidal coordination geometry is completed by the bidentate coordination mode of carboxylate, forming one type of trimeric unit. The Zn1 (Zn1) and Zn3 have similar coordination environments, only \u03bc2 bridging carboxylate becomes bidentate bridging, and thus, the vertex sharing polyhedrons are now separated. The coordination environment of Zn1 is completed by monodentate carboxylate forming another trimeric unit. These two types of trimeric units are connected by eight FDA ligands, respectively, which connect other trimeric units, forming a 3D structure (Figures S3 and S4 of the ). These two types of eight connected Zn3(RCOO)8 nodes give rise to two types of channels along the a axis: one is hydrophobic, and the other one is hydrophilic. The hydrophobic channels have dimensions of ~4.3 \u00d7 4.4 \u00c52 and are lined with the hydrocarbon part of the aromatic furan rings (Figure ). The channel contains hydrogen bonded DMF molecules arranged in such a way that the methyl groups will direct toward the hydrophobic walls (). The hydrophilic channels have dimensions ~5.6 \u00d7 6.2 \u00c52 and are decorated with furan oxygen and free carboxylic oxygen from monodentate coordination of furan carboxylates (Figure ). These channels also contain hydrogen bonded DMF molecules but are arranged in such a way that the carbonyl oxygens will direct toward the hydrophilic walls (). The PLATON analysis revealed that the 3D porous structure was composed of large voids of 2191.9 \u00c53 that represent 45.8% per unit cell volume.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Perspective view of the\nbiporous framework of compound <bold>2</bold> with hydrophobic hydrophilic\nchannels.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0001.tif\"></graphic>\n</fig>", "clean_text": " 2  Perspective view of the biporous framework of compound 2 with hydrophobic hydrophilic channels.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 9, "type": "text", "classification": "error", "content": "<p>It is now clear that the coordination number of\nthe central Zn\nremains octahedral while adjacent Zn centers in the trimeric unit\ndecrease from six (compound <bold>1</bold>) to five and four (compound <bold>2</bold>) with increasing temperature. This result motivated us to\ncheck if by increasing temperature we can get another phase with only\none type of trimeric Zn unit having a central octahedral and an adjacent\ntetrahedral Zn center. The reaction at 160 \u00b0C yielded compound <bold>3</bold>, having a 3D structure (Figure ).\nThe asymmetric unit contains two types of Zn centers. Zn1 have tetrahedral\ngeometry with full occupancy while Zn2 have octahedral geometry with\nhalf occupancy similar to the Zn1\u2013Zn3\u2013Zn1\u2032 unit\nin compound <bold>2</bold>. The only change is the bidentate bridging\ncarboxylate in compound <bold>2</bold> now becomes monodentate \u03bc<sub>2</sub>-O bridging; thus, the free polyhedra again become vertex\nsharing in compound <bold>3</bold> (Figures  and ). The trimeric units are connected by four FDA ligands\nin <italic toggle=\"yes\">bc</italic> plane to form a 2D sheet. Adjacent 2D sheets\nare connected at the trimeric units from both the sides by a pair\nof FDA ligands, leading to a 3D framework. The 3D framework has 1D\nchannels with dimensions \u223c5.3 \u00d7 6.2 \u00c5<sup>2</sup> and is occupied by disordered DMF molecules and DMA cations. The\nPLATON analysis revealed that the 3D\nporous structure was composed of large voids of 2521.4 \u00c5<sup>3</sup> that represent 54.4% per unit cell volume.</p>", "clean_text": "It is now clear that the coordination number of the central Zn remains octahedral while adjacent Zn centers in the trimeric unit decrease from six (compound 1) to five and four (compound 2) with increasing temperature. This result motivated us to check if by increasing temperature we can get another phase with only one type of trimeric Zn unit having a central octahedral and an adjacent tetrahedral Zn center. The reaction at 160 \u00b0C yielded compound 3, having a 3D structure (Figure ). The asymmetric unit contains two types of Zn centers. Zn1 have tetrahedral geometry with full occupancy while Zn2 have octahedral geometry with half occupancy similar to the Zn1-Zn3-Zn1' unit in compound 2. The only change is the bidentate bridging carboxylate in compound 2 now becomes monodentate \u03bc2-O bridging; thus, the free polyhedra again become vertex sharing in compound 3 (Figures  and ). The trimeric units are connected by four FDA ligands in bc plane to form a 2D sheet. Adjacent 2D sheets are connected at the trimeric units from both the sides by a pair of FDA ligands, leading to a 3D framework. The 3D framework has 1D channels with dimensions ~5.3 \u00d7 6.2 \u00c52 and is occupied by disordered DMF molecules and DMA cations. The PLATON analysis revealed that the 3D porous structure was composed of large voids of 2521.4 \u00c53 that represent 54.4% per unit cell volume.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Comparison of Zn<sub>3</sub>(RCOO)<sub>8</sub> eight connected\nnodes: (a) compound <bold>1</bold>; (b and c) compound <bold>2</bold>; (d) compound <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0002.tif\"></graphic>\n</fig>", "clean_text": " 3  Comparison of Zn3(RCOO)8 eight connected nodes: (a) compound 1; (b and c) compound 2; (d) compound 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "text", "classification": "error", "content": "<p>Interestingly, in total we observed a 2D structure\n(<bold>1</bold>) forming at lower temperature (90 \u00b0C) and a higher\nsymmetrical\nmonoporous 3D structure forming at higher temperature (160 \u00b0C)\nwith one intermediate lower symmetrical biporous 3D structure forming\nat intermediate temperature (120 \u00b0C). On air drying, all three\ncompounds lose disordered solvent molecules and transform to new unknown\nphases. But to our surprise we observed that the air-dried phases\nof compounds <bold>1</bold> and <bold>2</bold> have very similar PXRD\nand IR patterns (), although\ncompounds <bold>1</bold> and <bold>2</bold> have different structures.\nThis indicates that compound <bold>2</bold> loses solvent molecules\nand transforms to stable phase similar to which air-dried compound <bold>1</bold> transforms. The above results clearly show the role of reaction\ntemperature to change the lower dimensional structure to denser higher\ndimensions via one intermediate structure in Zn<sub>3</sub>(RCOO)<sub>8</sub> based supramolecular isomers (Table ). This type of systematic study on the role of different reaction\nparameters such as temperature may give us control over the desirable\nstructure of MOFs, which is very important for design of functional\nmaterials. Unfortunately, the exact mechanisms by which these parameters\naffect the structures are not well understood yet. We could not check\nthe porous properties of these above compounds, as compounds are losing\nsolvents at room temperature and changing structure, so the phase\npurities of the bulk phases are difficult to confirm from powder X-ray\ndiffraction data and elemental analysis.</p>", "clean_text": "Interestingly, in total we observed a 2D structure (1) forming at lower temperature (90 \u00b0C) and a higher symmetrical monoporous 3D structure forming at higher temperature (160 \u00b0C) with one intermediate lower symmetrical biporous 3D structure forming at intermediate temperature (120 \u00b0C). On air drying, all three compounds lose disordered solvent molecules and transform to new unknown phases. But to our surprise we observed that the air-dried phases of compounds 1 and 2 have very similar PXRD and IR patterns (), although compounds 1 and 2 have different structures. This indicates that compound 2 loses solvent molecules and transforms to stable phase similar to which air-dried compound 1 transforms. The above results clearly show the role of reaction temperature to change the lower dimensional structure to denser higher dimensions via one intermediate structure in Zn3(RCOO)8 based supramolecular isomers (Table ). This type of systematic study on the role of different reaction parameters such as temperature may give us control over the desirable structure of MOFs, which is very important for design of functional materials. Unfortunately, the exact mechanisms by which these parameters affect the structures are not well understood yet. We could not check the porous properties of these above compounds, as compounds are losing solvents at room temperature and changing structure, so the phase purities of the bulk phases are difficult to confirm from powder X-ray diffraction data and elemental analysis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 12, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Data for Three Compounds Synthesized\nin the Series<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref27\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref28\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref29\"></xref>\n</named-content>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\" \" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">synthesis temp</oasis:entry>\n<oasis:entry align=\"center\">formula</oasis:entry>\n<oasis:entry align=\"center\">dimensionality</oasis:entry>\n<oasis:entry align=\"center\"> coordination\ngeometry of trimeric Zn centers</oasis:entry>\n<oasis:entry align=\"center\">pore\ntypes</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>90 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>2D</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub> (d)\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub> (d)</oasis:entry>\n<oasis:entry>porous</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>120 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>3D</oasis:entry>\n<oasis:entry>tbp (d)\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013tbp\n(d) and <italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\n</oasis:entry>\n<oasis:entry>biporous</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>160 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>3D</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\n</oasis:entry>\n<oasis:entry>porous</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<p>In conclusion, we have synthesized three anionic MOFs\nhaving general\nformula [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)] from the same starting materials by a solvothermal technique.\nThe dimensionality control was obtained by a temperature tuning strategy\nwhich is attributed to the changes in the local environment around\nthe Zn centers with increasing temperature. To the best of our knowledge,\nthis is the first time we have shown the simultaneous control over\ndimensionality with supramolecular isomerism on MOFs.</p>", "clean_text": "In conclusion, we have synthesized three anionic MOFs having general formula [Zn1.5(FDA)2(Me2NH2)] from the same starting materials by a solvothermal technique. The dimensionality control was obtained by a temperature tuning strategy which is attributed to the changes in the local environment around the Zn centers with increasing temperature. To the best of our knowledge, this is the first time we have shown the simultaneous control over dimensionality with supramolecular isomerism on MOFs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<p>X-ray crystallographic data\nof compounds <bold>1</bold>\u2013<bold>3</bold> in cif format, table\nof selected bond angles and bond lengths, and figures. This material\nis available free of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p>", "clean_text": "X-ray crystallographic data of compounds 1-3 in cif format, table of selected bond angles and bond lengths, and figures. This material is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": ["property"], "content": "<title>References</title><p>Crystal\ndata for compound <bold>1</bold>:\nC<sub>14</sub>H<sub>12</sub>NO<sub>10</sub>Zn<sub>1.5</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 452.30, triclinic, space group <italic toggle=\"yes\">P</italic>1\u0305, <italic toggle=\"yes\">a</italic> = 9.3167 (16) \u00c5, <italic toggle=\"yes\">b</italic> = 9.8122 (17) \u00c5, <italic toggle=\"yes\">c</italic> = 11.596 (2) \u00c5, <italic toggle=\"yes\">V</italic> = 1035.8(3) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> = 2, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.450 mg/m<sup>3</sup>, final <italic toggle=\"yes\">R1</italic> = 0.0347 and <italic toggle=\"yes\">wR2</italic> = 0.1171 for 18291\nindependent reflections [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856831.</p>", "clean_text": "References\n\nCrystal data for compound 1: C14H12NO10Zn1.5, M r = 452.30, triclinic, space group P1\u0305, a = 9.3167 (16) \u00c5, b = 9.8122 (17) \u00c5, c = 11.596 (2) \u00c5, V = 1035.8(3) \u00c53, Z = 2, F calcd = 1.450 mg/m3, final R1 = 0.0347 and wR2 = 0.1171 for 18291 independent reflections [I > 2\u03c3(I)]. CCDC-856831.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 16, "type": "text", "classification": ["property"], "content": "<p>Crystal data for compound <bold>2</bold>:\nC<sub>28</sub>H<sub>24</sub>N<sub>2</sub>O<sub>20</sub>Zn<sub>3</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 904.60, triclinic, space group <italic toggle=\"yes\">P</italic>1\u0305, <italic toggle=\"yes\">a</italic> = 12.7693 (10) \u00c5, <italic toggle=\"yes\">b</italic> = 12.7842 (9) \u00c5, <italic toggle=\"yes\">c</italic> = 14.7758 (11)\n\u00c5, <italic toggle=\"yes\">V</italic> = 2191.9 (3) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> = 2, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.371 mg/m<sup>3</sup>, final <italic toggle=\"yes\">R1</italic> = 0.0312 and <italic toggle=\"yes\">wR2</italic> = 0.0958 for 11299 independent reflections [<italic toggle=\"yes\">I</italic> &gt;\n2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856832.</p>", "clean_text": "Crystal data for compound 2: C28H24N2O20Zn3, M r = 904.60, triclinic, space group P1\u0305, a = 12.7693 (10) \u00c5, b = 12.7842 (9) \u00c5, c = 14.7758 (11) \u00c5, V = 2191.9 (3) \u00c53, Z = 2, F calcd = 1.371 mg/m3, final R1 = 0.0312 and wR2 = 0.0958 for 11299 independent reflections [I > 2\u03c3(I)]. CCDC-856832.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 17, "type": "text", "classification": ["property"], "content": "<p>Crystal data for compound <bold>3</bold>:\nC<sub>14</sub>H<sub>12</sub>NO<sub>10</sub>Zn<sub>1.5</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 452.30, monoclinic, space group <italic toggle=\"yes\">P</italic>21/<italic toggle=\"yes\">c</italic>, <italic toggle=\"yes\">a</italic> = 9.426 (5) \u00c5, <italic toggle=\"yes\">b</italic> = 15.424 (5) \u00c5, <italic toggle=\"yes\">c</italic> = 17.359 (5) \u00c5, <italic toggle=\"yes\">V</italic> = 2521.4(17) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> =\n4, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.191 m g /m<sup>3</sup>,\nfinal <italic toggle=\"yes\">R1</italic> = 0.1038 and <italic toggle=\"yes\">wR2</italic> = 0.3523\nfor 6457 independent reflections [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856833.</p>", "clean_text": "Crystal data for compound 3: C14H12NO10Zn1.5, M r = 452.30, monoclinic, space group P21/c, a = 9.426 (5) \u00c5, b = 15.424 (5) \u00c5, c = 17.359 (5) \u00c5, V = 2521.4(17) \u00c53, Z = 4, F calcd = 1.191 m g /m3, final R1 = 0.1038 and wR2 = 0.3523 for 6457 independent reflections [I > 2\u03c3(I)]. CCDC-856833.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}], "cln_elements": [{"idx": "1, 15, 16, 17", "type": "text", "classification": "property", "content": "<p>Three new anionic metal organic frameworks, [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>1</bold>), [Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>2</bold>),\nand [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G (<bold>3</bold>) (FDAH<sub>2</sub> =\n2,5-furandicarboxylic acid, G = guest), were synthesized solvothermally\nvia a temperature tuning strategy. Compound <bold>1</bold>, synthesized\nat 90 \u00b0C, has a two-dimensional (2D) sheet structure, while <bold>2</bold> and <bold>3</bold>, synthesized at 120 and 160 \u00b0C,\nrespectively, have three-dimensional (3D) structures. Compound <bold>2</bold> has alternating hydrophobic and hydrophilic channels with\npore dimensions \u223c4.3 \u00d7 4.4 \u00c5<sup>2</sup> and \u223c5.6\n\u00d7 6.2 \u00c5<sup>2</sup>, respectively. Compound <bold>3</bold> has only one type of pore with dimensions of \u223c5.3 \u00d7\n6.2 \u00c5<sup>2</sup>. All three compounds have eight connected Zn<sub>3</sub>(RCOO)<sub>8</sub> nodes as building units and are anionic,\nwith dimethyl ammonium cations present inside the channels to balance\ncharge. Compounds <bold>1</bold>, <bold>2</bold>, and <bold>3</bold> are supramolecular isomers with general formula [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]<sub>\n<italic toggle=\"yes\">n</italic>\n</sub>.</p><title>References</title><p>Crystal\ndata for compound <bold>1</bold>:\nC<sub>14</sub>H<sub>12</sub>NO<sub>10</sub>Zn<sub>1.5</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 452.30, triclinic, space group <italic toggle=\"yes\">P</italic>1\u0305, <italic toggle=\"yes\">a</italic> = 9.3167 (16) \u00c5, <italic toggle=\"yes\">b</italic> = 9.8122 (17) \u00c5, <italic toggle=\"yes\">c</italic> = 11.596 (2) \u00c5, <italic toggle=\"yes\">V</italic> = 1035.8(3) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> = 2, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.450 mg/m<sup>3</sup>, final <italic toggle=\"yes\">R1</italic> = 0.0347 and <italic toggle=\"yes\">wR2</italic> = 0.1171 for 18291\nindependent reflections [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856831.</p><p>Crystal data for compound <bold>2</bold>:\nC<sub>28</sub>H<sub>24</sub>N<sub>2</sub>O<sub>20</sub>Zn<sub>3</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 904.60, triclinic, space group <italic toggle=\"yes\">P</italic>1\u0305, <italic toggle=\"yes\">a</italic> = 12.7693 (10) \u00c5, <italic toggle=\"yes\">b</italic> = 12.7842 (9) \u00c5, <italic toggle=\"yes\">c</italic> = 14.7758 (11)\n\u00c5, <italic toggle=\"yes\">V</italic> = 2191.9 (3) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> = 2, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.371 mg/m<sup>3</sup>, final <italic toggle=\"yes\">R1</italic> = 0.0312 and <italic toggle=\"yes\">wR2</italic> = 0.0958 for 11299 independent reflections [<italic toggle=\"yes\">I</italic> &gt;\n2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856832.</p><p>Crystal data for compound <bold>3</bold>:\nC<sub>14</sub>H<sub>12</sub>NO<sub>10</sub>Zn<sub>1.5</sub>, <italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 452.30, monoclinic, space group <italic toggle=\"yes\">P</italic>21/<italic toggle=\"yes\">c</italic>, <italic toggle=\"yes\">a</italic> = 9.426 (5) \u00c5, <italic toggle=\"yes\">b</italic> = 15.424 (5) \u00c5, <italic toggle=\"yes\">c</italic> = 17.359 (5) \u00c5, <italic toggle=\"yes\">V</italic> = 2521.4(17) \u00c5<sup>3</sup>, <italic toggle=\"yes\">Z</italic> =\n4, <italic toggle=\"yes\">F</italic>\n<sub>calcd</sub> = 1.191 m g /m<sup>3</sup>,\nfinal <italic toggle=\"yes\">R1</italic> = 0.1038 and <italic toggle=\"yes\">wR2</italic> = 0.3523\nfor 6457 independent reflections [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]. CCDC-856833.</p>", "clean_text": "Three new anionic metal organic frameworks, [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (1), [Zn3(FDA)4(Me2NH2)2]\u22c5xG (2), and [Zn1.5(FDA)2(Me2NH2)]\u22c5xG (3) (FDAH2 = 2,5-furandicarboxylic acid, G = guest), were synthesized solvothermally via a temperature tuning strategy. Compound 1, synthesized at 90 \u00b0C, has a two-dimensional (2D) sheet structure, while 2 and 3, synthesized at 120 and 160 \u00b0C, respectively, have three-dimensional (3D) structures. Compound 2 has alternating hydrophobic and hydrophilic channels with pore dimensions ~4.3 \u00d7 4.4 \u00c52 and ~5.6 \u00d7 6.2 \u00c52, respectively. Compound 3 has only one type of pore with dimensions of ~5.3 \u00d7 6.2 \u00c52. All three compounds have eight connected Zn3(RCOO)8 nodes as building units and are anionic, with dimethyl ammonium cations present inside the channels to balance charge. Compounds 1, 2, and 3 are supramolecular isomers with general formula [Zn1.5(FDA)2(Me2NH2)] n .\n\nReferences\n\nCrystal data for compound 1: C14H12NO10Zn1.5, M r = 452.30, triclinic, space group P1\u0305, a = 9.3167 (16) \u00c5, b = 9.8122 (17) \u00c5, c = 11.596 (2) \u00c5, V = 1035.8(3) \u00c53, Z = 2, F calcd = 1.450 mg/m3, final R1 = 0.0347 and wR2 = 0.1171 for 18291 independent reflections [I > 2\u03c3(I)]. CCDC-856831.\n\nCrystal data for compound 2: C28H24N2O20Zn3, M r = 904.60, triclinic, space group P1\u0305, a = 12.7693 (10) \u00c5, b = 12.7842 (9) \u00c5, c = 14.7758 (11) \u00c5, V = 2191.9 (3) \u00c53, Z = 2, F calcd = 1.371 mg/m3, final R1 = 0.0312 and wR2 = 0.0958 for 11299 independent reflections [I > 2\u03c3(I)]. CCDC-856832.\n\nCrystal data for compound 3: C14H12NO10Zn1.5, M r = 452.30, monoclinic, space group P21/c, a = 9.426 (5) \u00c5, b = 15.424 (5) \u00c5, c = 17.359 (5) \u00c5, V = 2521.4(17) \u00c53, Z = 4, F calcd = 1.191 m g /m3, final R1 = 0.1038 and wR2 = 0.3523 for 6457 independent reflections [I > 2\u03c3(I)]. CCDC-856833.", "data": [[[{"meta": {"name": "", "symbol": "1", "chemical formula": "[Zn1.5(FDA)2(Me2NH2)]\u22c5xG"}, "chemical formula weight": [{"value": "452.30", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "9.3167", "b": "9.8122", "c": "11.596", "alpha": "", "beta": "", "gamma": "", "condition": ""}}], "density": [{"value": "1.450", "unit": "mg/m3", "condition": ""}]}, {"meta": {"name": "", "symbol": "2", "chemical formula": "[Zn3(FDA)4(Me2NH2)2]\u22c5xG"}, "chemical formula weight": [{"value": "904.60", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "12.7693", "b": "12.7842", "c": "14.7758", "alpha": "", "beta": "", "gamma": "", "condition": ""}}], "density": [{"value": "1.371", "unit": "mg/m3", "condition": ""}]}, {"meta": {"name": "", "symbol": "3", "chemical formula": "[Zn1.5(FDA)2(Me2NH2)]\u22c5xG"}, "chemical formula weight": [{"value": "452.30", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P21/c", "condition": ""}], "lattice parameters": [{"value": {"a": "9.426", "b": "15.424", "c": "17.359", "alpha": "", "beta": "", "gamma": "", "condition": ""}}], "density": [{"value": "1.191", "unit": "mg/m3", "condition": ""}]}]]], "include_properties": ["chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "density"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['chemical_formula_weight', 'crystal_system', 'space_group', 'lattice_parameters', 'density']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"[Zn1.5(FDA)2(Me2NH2)]\u22c5xG\"\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"452.30\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\"\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\"\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\"\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.3167\",\n                    \"b\": \"9.8122\",\n                    \"c\": \"11.596\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                    \"condition\": \"\"\n                }\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.450\",\n                \"unit\": \"mg/m3\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"[Zn3(FDA)4(Me2NH2)2]\u22c5xG\"\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"904.60\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\"\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\"\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\"\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"12.7693\",\n                    \"b\": \"12.7842\",\n                    \"c\": \"14.7758\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                    \"condition\": \"\"\n                }\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.371\",\n                \"unit\": \"mg/m3\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"[Zn1.5(FDA)2(Me2NH2)]\u22c5xG\"\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"452.30\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\"\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\"\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P21/c\",\n                \"condition\": \"\"\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.426\",\n                    \"b\": \"15.424\",\n                    \"c\": \"17.359\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                    \"condition\": \"\"\n                }\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.191\",\n                \"unit\": \"mg/m3\",\n                \"condition\": \"\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 12, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Data for Three Compounds Synthesized\nin the Series<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref27\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref28\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref29\"></xref>\n</named-content>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\" \" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">synthesis temp</oasis:entry>\n<oasis:entry align=\"center\">formula</oasis:entry>\n<oasis:entry align=\"center\">dimensionality</oasis:entry>\n<oasis:entry align=\"center\"> coordination\ngeometry of trimeric Zn centers</oasis:entry>\n<oasis:entry align=\"center\">pore\ntypes</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>90 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>2D</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub> (d)\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub> (d)</oasis:entry>\n<oasis:entry>porous</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>120 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>3D</oasis:entry>\n<oasis:entry>tbp (d)\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013tbp\n(d) and <italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\n</oasis:entry>\n<oasis:entry>biporous</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>160 \u00b0C</oasis:entry>\n<oasis:entry>[Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7<italic toggle=\"yes\">x</italic>G</oasis:entry>\n<oasis:entry>3D</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\u2013<italic toggle=\"yes\">O</italic>\n<sub>\n<italic toggle=\"yes\">h</italic>\n</sub>\u2013<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">d</italic>\n</sub>\n</oasis:entry>\n<oasis:entry>porous</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 1. Data for Three Compounds Synthesized in the Series[^27][^29]\n\n| compd | synthesis temp | formula | dimensionality | coordination geometry of trimeric Zn centers | pore types |\n|-------|-----------------|---------|-----------------|------------------------------------------------|------------|\n| 1     | 90 \u00b0C           | [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7*x*G | 2D | *O*<sub>*h*</sub> (d)\u2013*O*<sub>*h*</sub>\u2013*O*<sub>*h*</sub> (d) | porous |\n| 2     | 120 \u00b0C          | [Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7*x*G | 3D | tbp (d)\u2013*O*<sub>*h*</sub>\u2013tbp (d) and *T*<sub>*d*</sub>\u2013*O*<sub>*h*</sub>\u2013*T*<sub>*d*</sub> | biporous |\n| 3     | 160 \u00b0C          | [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7*x*G | 3D | *T*<sub>*d*</sub>\u2013*O*<sub>*h*</sub>\u2013*T*<sub>*d*</sub> | porous |", "data": [[{"meta": {"name": "1", "symbol": "", "chemical formula": "[Zn1.5(FDA)2(Me2NH2)]\u00b7xG"}, "material shape": [], "etc": [{"property name": "synthesis temp", "value": "90", "unit": "\u00b0C", "condition": ""}, {"property name": "dimensionality", "value": "2D", "condition": ""}, {"property name": "coordination geometry of trimeric Zn centers", "value": "Oh (d)\u2013Oh\u2013Oh (d)", "condition": ""}, {"property name": "pore types", "value": "porous", "condition": ""}]}, {"meta": {"name": "2", "symbol": "", "chemical formula": "[Zn3(FDA)4(Me2NH2)2]\u00b7xG"}, "material shape": [], "etc": [{"property name": "synthesis temp", "value": "120", "unit": "\u00b0C", "condition": ""}, {"property name": "dimensionality", "value": "3D", "condition": ""}, {"property name": "coordination geometry of trimeric Zn centers", "value": "tbp (d)\u2013Oh\u2013tbp (d) and Td\u2013Oh\u2013Td", "condition": ""}, {"property name": "pore types", "value": "biporous", "condition": ""}]}, {"meta": {"name": "3", "symbol": "", "chemical formula": "[Zn1.5(FDA)2(Me2NH2)]\u00b7xG"}, "material shape": [], "etc": [{"property name": "synthesis temp", "value": "160", "unit": "\u00b0C", "condition": ""}, {"property name": "dimensionality", "value": "3D", "condition": ""}, {"property name": "coordination geometry of trimeric Zn centers", "value": "Td\u2013Oh\u2013Td", "condition": ""}, {"property name": "pore types", "value": "porous", "condition": ""}]}]], "include_properties": ["material_shape", "etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Data for Three Compounds Synthesized in the Series[^27][^29]\n\n| compd | synthesis temp | formula | dimensionality | coordination geometry of trimeric Zn centers | pore types |\n|-------|-----------------|---------|-----------------|------------------------------------------------|------------|\n| 1     | 90 \u00b0C           | [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7*x*G | 2D | *O*<sub>*h*</sub> (d)\u2013*O*<sub>*h*</sub>\u2013*O*<sub>*h*</sub> (d) | porous |\n| 2     | 120 \u00b0C          | [Zn<sub>3</sub>(FDA)<sub>4</sub>(Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>]\u00b7*x*G | 3D | tbp (d)\u2013*O*<sub>*h*</sub>\u2013tbp (d) and *T*<sub>*d*</sub>\u2013*O*<sub>*h*</sub>\u2013*T*<sub>*d*</sub> | biporous |\n| 3     | 160 \u00b0C          | [Zn<sub>1.5</sub>(FDA)<sub>2</sub>(Me<sub>2</sub>NH<sub>2</sub>)]\u00b7*x*G | 3D | *T*<sub>*d*</sub>\u2013*O*<sub>*h*</sub>\u2013*T*<sub>*d*</sub> | porous |\n<END>", "table-categorize": "Property", "table-property-type": "['material_shape', 'etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn1.5(FDA)2(Me2NH2)]\u00b7xG\",\n        },\n        \"material shape\": [],\n        \"etc\": [\n            {\n                \"property name\": \"synthesis temp\",\n                \"value\": \"90\",\n                \"unit\": \"\u00b0C\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"dimensionality\",\n                \"value\": \"2D\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"coordination geometry of trimeric Zn centers\",\n                \"value\": \"Oh (d)\u2013Oh\u2013Oh (d)\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pore types\",\n                \"value\": \"porous\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn3(FDA)4(Me2NH2)2]\u00b7xG\",\n        },\n        \"material shape\": [],\n        \"etc\": [\n            {\n                \"property name\": \"synthesis temp\",\n                \"value\": \"120\",\n                \"unit\": \"\u00b0C\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"dimensionality\",\n                \"value\": \"3D\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"coordination geometry of trimeric Zn centers\",\n                \"value\": \"tbp (d)\u2013Oh\u2013tbp (d) and Td\u2013Oh\u2013Td\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pore types\",\n                \"value\": \"biporous\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn1.5(FDA)2(Me2NH2)]\u00b7xG\",\n        },\n        \"material shape\": [],\n        \"etc\": [\n            {\n                \"property name\": \"synthesis temp\",\n                \"value\": \"160\",\n                \"unit\": \"\u00b0C\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"dimensionality\",\n                \"value\": \"3D\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"coordination geometry of trimeric Zn centers\",\n                \"value\": \"Td\u2013Oh\u2013Td\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pore types\",\n                \"value\": \"porous\",\n                \"condition\": \"\",\n            }\n        ],\n    }\n]\n```"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Temperature dependent synthesis of porous compounds <bold>1</bold>\u2013<bold>3</bold>, and the changes in coordination environment\nof trimeric Zn units. (Color code: zinc, yellow; carbon, gray; oxygen,\nred. Hydrogen atoms and disordered solvents, and extra framework cations\nare omitted for clarity.).</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0005.tif\"></graphic>\n</fig>", "clean_text": " 1  Temperature dependent synthesis of porous compounds 1-3, and the changes in coordination environment of trimeric Zn units. (Color code: zinc, yellow; carbon, gray; oxygen, red. Hydrogen atoms and disordered solvents, and extra framework cations are omitted for clarity.).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Perspective view of the\nbiporous framework of compound <bold>2</bold> with hydrophobic hydrophilic\nchannels.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0001.tif\"></graphic>\n</fig>", "clean_text": " 2  Perspective view of the biporous framework of compound 2 with hydrophobic hydrophilic channels.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Comparison of Zn<sub>3</sub>(RCOO)<sub>8</sub> eight connected\nnodes: (a) compound <bold>1</bold>; (b and c) compound <bold>2</bold>; (d) compound <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01630c_0002.tif\"></graphic>\n</fig>", "clean_text": " 3  Comparison of Zn3(RCOO)8 eight connected nodes: (a) compound 1; (b and c) compound 2; (d) compound 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/cg201630c", "title": "\nRole of Temperature on\nFramework Dimensionality: Supramolecular\nIsomers of Zn3(RCOO)8 Based Metal Organic Frameworks\n", "journal": "American Chemical\nSociety", "date": "2012.01", "author_list": ["Nagarkar\nSanjog\nS.", "Chaudhari\nAbhijeet K.", "Ghosh\nSujit K."]}}